User profiles for Gérard Krause
 | Gérard KrauseHead of Epidemiology Dept., Helmholtz Centre for Infection Research, Braunschweig … Verified email at helmholtz-hzi.de Cited by 17150 |
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
A Schweitzer, J Horn, RT Mikolajczyk, G Krause, JJ Ott - The Lancet, 2015 - thelancet.com
Background The quantification of the burden of disease attributable to hepatitis B virus (HBV)
infection and the adaptation of prevention and control measures requires knowledge on its …
infection and the adaptation of prevention and control measures requires knowledge on its …
[HTML][HTML] SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
T cell immunity is central for the control of viral infections. To characterize T cell immunity,
but also for the development of vaccines, identification of exact viral T cell epitopes is …
but also for the development of vaccines, identification of exact viral T cell epitopes is …
Time trends of chronic HBV infection over prior decades–a global analysis
JJ Ott, J Horn, G Krause, RT Mikolajczyk - Journal of Hepatology, 2017 - Elsevier
Background & Aims Information on trends in chronic hepatitis B virus (HBV) prevalence across
countries is lacking. We studied changes in chronic HBV infection over previous decades …
countries is lacking. We studied changes in chronic HBV infection over previous decades …
[HTML][HTML] Epidemic Profile of Shiga-Toxin–Producing Escherichia coli O104:H4 Outbreak in Germany
…, B Rosner, U Buchholz, K Stark, G Krause - … England Journal of …, 2011 - Mass Medical Soc
Background We describe an outbreak of gastroenteritis and the hemolytic–uremic syndrome
caused by Shiga-toxin–producing Escherichia coli in Germany in May, June, and July, 2011…
caused by Shiga-toxin–producing Escherichia coli in Germany in May, June, and July, 2011…
[HTML][HTML] SurvNet electronic surveillance system for infectious disease outbreaks, Germany
In 2001, the Robert Koch Institute (RKI) implemented a new electronic surveillance system (SurvNet)
for infectious disease outbreaks in Germany. SurvNet has captured 30,578 …
for infectious disease outbreaks in Germany. SurvNet has captured 30,578 …
[HTML][HTML] German Outbreak of Escherichia coli O104:H4 Associated with Sprouts
…, U Jark, M Kirchner, J Koch, G Krause… - … England Journal of …, 2011 - Mass Medical Soc
Background A large outbreak of the hemolytic–uremic syndrome caused by Shiga-toxin–producing
Escherichia coli O104:H4 occurred in Germany in May 2011. The source of infection …
Escherichia coli O104:H4 occurred in Germany in May 2011. The source of infection …
[HTML][HTML] Immune response to SARS-CoV-2 variants of concern in vaccinated individuals
SARS-CoV-2 is evolving with mutations in the receptor binding domain (RBD) being of
particular concern. It is important to know how much cross-protection is offered between strains …
particular concern. It is important to know how much cross-protection is offered between strains …
[HTML][HTML] The role of facemasks and hand hygiene in the prevention of influenza transmission in households: results from a cluster randomised trial; Berlin, Germany …
…, J Milde, W Haas, I Koehler, G Krause… - BMC infectious …, 2012 - Springer
Background Previous controlled studies on the effect of non-pharmaceutical interventions (NPI)
- namely the use of facemasks and intensified hand hygiene - in preventing household …
- namely the use of facemasks and intensified hand hygiene - in preventing household …
[HTML][HTML] Communicable diseases prioritized for surveillance and epidemiological research: results of a standardized prioritization procedure in Germany, 2011
…, K Stark, N Suttorp, U Ulbrich, O Wichmann, G Krause - PloS one, 2011 - journals.plos.org
Introduction To establish strategic priorities for the German national public health institute (RKI)
and guide the institute's mid-term strategic decisions, we prioritized infectious pathogens …
and guide the institute's mid-term strategic decisions, we prioritized infectious pathogens …
[HTML][HTML] Herpes zoster in Germany: quantifying the burden of disease
…, A Siedler, T Rieck, T Reinhold, G Krause… - BMC infectious …, 2011 - Springer
Background Herpes zoster (HZ) is caused by a reactivation of the varicella-zoster-virus (VZV)
and mainly affects individuals aged ≥ 50 years. Vaccines have been licensed or are under …
and mainly affects individuals aged ≥ 50 years. Vaccines have been licensed or are under …
